CRISPR-Cas9 pioneer presented with National Medal of Technology and Innovation in White House awards ceremony.

Jennifer Doudna, a UC Berkeley biochemist who shared the 2020 Nobel Prize in Chemistry for the invention of CRISPR-Cas9 ...

Gene editing involves precise changes in DNA sequences using enzymes, revolutionizing medical, agricultural, and research ...

Looking at the volume and open interest is an insightful way to conduct due diligence on a stock. This data can help you ...

The revolution in artificial intelligence (AI) and genetic engineering represents an unprecedented turning point in human ...

A research team led by Prof. Qin Guozheng from the Institute of Botany of the Chinese Academy of Sciences has unveiled a ...

Brookline Capital Management boosted their FY2024 earnings per share estimates for CRISPR Therapeutics in a research note issued on Monday, January 6th. Brookline Capital Management analyst L. Cann ...

For modern biotherapeutics, cell line development workflows must include more than just automated liquid handling.

The science has proven that gene therapies are effective treatments, and they have given hope to patients and their families ...

Biochemist Jennifer Doudna, a faculty scientist at the Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab), founder of the ...

This Fool has his eye on an innovative growth stock that has plunged by 80% since early 2021. But what is so special about it ...